MFAP4 and pulmonary arterial hypertension: MFAP4 has been proposed as a new candidate gene for left-sided congenital heart syndrome [15], and using proteome analysis, MFAP4 expression has been associated with aortic aneurysms [16], [17], pulmonary hypertension [18] and cirrhotic disease [19].